The cumulative 3-year OS, PFS, and DFS rate of the cohort of 89 Nogo-B+p-RhoA+ NPC patients were 82.0, 80.9, and 80.9% respectively (Fig. 7B, Supplementary Fig. 2F). The gene discussed is RTN4; the disease is nasopharyngeal carcinoma.